Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Therapeutic Drug Carrier Systems
Fator do impacto: 2.9 FI de cinco anos: 3.72 SJR: 0.736 SNIP: 0.818 CiteScore™: 4.6

ISSN Imprimir: 0743-4863
ISSN On-line: 2162-660X

Volumes:
Volume 37, 2020 Volume 36, 2019 Volume 35, 2018 Volume 34, 2017 Volume 33, 2016 Volume 32, 2015 Volume 31, 2014 Volume 30, 2013 Volume 29, 2012 Volume 28, 2011 Volume 27, 2010 Volume 26, 2009 Volume 25, 2008 Volume 24, 2007 Volume 23, 2006 Volume 22, 2005 Volume 21, 2004 Volume 20, 2003 Volume 19, 2002 Volume 18, 2001 Volume 17, 2000 Volume 16, 1999 Volume 15, 1998 Volume 14, 1997 Volume 13, 1996 Volume 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.2013005964
pages 217-256

Drug Carrier Systems for Solubility Enhancement of BCS Class II Drugs: A Critical Review

Sumit Kumar
Nanomedicine Research Lab, Department of Pharmaceutics, ISF College of Pharmacy, Moga
Deepak Bhargava
Department of Quality Assurance, ISF College of Pharmacy, Moga
Arti Thakkar
Department of Quality Assurance, ISF College of Pharmacy, Moga
Saahil Arora
Department of Pharmaceutics, ISF College of Pharmacy, Moga (Punjab), India 09501223252(M)

RESUMO

Poor aqueous solubility impedes a drug's bioavailability and challenges its pharmaceutical development. Pharmaceutical development of drugs with poor water solubility requires the establishment of a suitable formulation layout among various techniques. Various approaches have been investigated extensively to improve the aqueous solubility and poor dissolution rate of BCS class II and IV drugs. In this literature review, novel formulation options, particularly for class II drugs designed for applications such as micronization, self-emulsification, cyclodextrin complexation, co-crystallisation, super critical fluid technology, solubilisation by change in pH, salt formation, co-solvents, melt granulation, and solid dispersion, liposomal/niosomal formulations, are discussed in detail to introduce biopharmaceutical challenges and recent approaches to facilitate more efficient drug formulation and development.


Articles with similar content:

Lipids and Surfactants: The Inside Story of Lipid-Based Drug Delivery Systems
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.35, 2018, issue 2
Seema Kohli, Vikas Pandey
Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.33, 2016, issue 1
Rohit Karwal, Tanmay S. Markandeywar, Goutam Rath, Tarun Garg
Self-Emulsifying Drug Delivery System (SEDDS): An Emerging Dosage Form to Improve the Bioavailability of Poorly Absorbed Drugs
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.37, 2020, issue 4
Pradeep Mishra, Meenakshi Bajpai, Sonia Singh
Paclitaxel in Cancer Treatment: Perspectives and Prospects of its Delivery Challenges
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.26, 2009, issue 4
Somnath Singh, Alekha K. Dash
Pharmaceutical Cocrystals: A Novel Approach for Oral Bioavailability Enhancement of Drugs
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.29, 2012, issue 3
Renu Chadha, Poonam Arora, Swati Bhandari, Anupam Saini